학술논문
Efficacy of Lorlatinib in Treatment-Naive Patients With ALK-Positive Advanced NSCLC in Relation to EML4::ALK Variant Type and ALK With or Without TP53 Mutations
Document Type
Article
Author
Source
In Journal of Thoracic Oncology November 2023 18(11):1581-1593
Subject
Language
ISSN
1556-0864